Suzuki Naoki, Tateyama Maki, Warita Hitoshi, Izumi Rumiko, Nishino Ichizo, Aoki Masashi
Department of Neurology, Tohoku University School of Medicine.
Rinsho Shinkeigaku. 2011 Nov;51(11):964-6. doi: 10.5692/clinicalneurol.51.964.
Sporadic inclusion body myositis (sIBM) is an intractable and progressive skeletal muscle disease of unknown cause and without effective treatment. The etiology of sIBM is still unknown, however genetic factors, aging, life styles, environmental factors may be involved. sIBM is generally refractory to current therapy, such as steroid or immunosuppressants. To elucidate the pathomechanism of sIBM is the most important way to make therapeutic approach. In this review we estimated the prevalence of sIBM in Japan and discuss the pathomechanism of sIBM.
散发性包涵体肌炎(sIBM)是一种病因不明且无有效治疗方法的难治性进行性骨骼肌疾病。sIBM的病因仍不清楚,然而,遗传因素、衰老、生活方式、环境因素可能都与之相关。sIBM通常对目前的治疗方法,如类固醇或免疫抑制剂治疗无效。阐明sIBM的发病机制是制定治疗方案的最重要途径。在这篇综述中,我们评估了sIBM在日本的患病率,并探讨了sIBM的发病机制。